Literature DB >> 6174451

Characterization of herpes simplex virus persistence in a human T lymphoblastoid cell line.

P J Cummings, R J Lakomy, C R Rinaldo.   

Abstract

Persistent, dynamic-state infection with herpes simplex virus (HSV) type 1 has been maintained in human T lymphoblastoid (CEM) cells for many months after initial infection with the wild-type virus (HSV0) (input virus/cell multiplicity of 1.0). Persistently infected cells grew as well as uninfected cells, except during occasional periods of crisis (increased viral replication and cytopathic effect). Cells could survive the crisis when they were maintained for twice the usual time interval (8 to 10 rather than 4 to 5 days) before subculture. Interferon was not detectable in the cultures. HSV0 was compared with HSVp1, a small plaque-forming isolate from persistently infected CEM cells. Primary infection of CEM cells with HSV0 at a low input multiplicity (0.01) led to abortive replication, whereas infection with HSVp1 at the same multiplicity resulted in either rapidly lytic or persistent infection depending upon the time interval of subculture. Approximately 55% of plaque-purified clones of HSVp1, as compared with only 5% of HSV0 clones, displayed temperature-sensitive growth in Vero cells. Defective interfering virus was not detectable in uncloned HSVp1 by interference assay. Persistently infected cultures "cured" by treatment with HSV antiserum or incubation at 39 degrees C were resistant to reinfection with HSV but permissive for vesicular stomatitis virus replication, suggesting that these treatments modulated a shift from the dynamic-state of the static-state, latent infection. These studies provide a model for characterization of HSV persistence and latency in a highly differentiated human cell line.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174451      PMCID: PMC350943          DOI: 10.1128/iai.34.3.817-827.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Further characterization of herpes virus persistence.

Authors:  J E Dunn; W J Meinke; J Spizizen
Journal:  J Gen Virol       Date:  1979-05       Impact factor: 3.891

Review 2.  Latent herpes simplex virus and the nervous system,.

Authors:  J G Stevens
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

3.  Persistent infection of a human lymphocyte cell line (Molt-4) with the kilham rat virus.

Authors:  L R Bass; F M Hetrick
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

4.  Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro.

Authors:  J J Holland; L P Villarreal; R M Welsh; M B Oldstone; D Kohne; R Lazzarini; E Scolnick
Journal:  J Gen Virol       Date:  1976-11       Impact factor: 3.891

5.  Hepatitis in an adult caused by Herpes simplex virus type I.

Authors:  L Eron; K Kosinski; M S Hirsch
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

6.  Persistence of herpes simplex virus type 1 in rat neurotumor cells.

Authors:  E Doller; J Aucker; A Weissbach
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

7.  Resistance of hamster cells transformed by herpes simplex virus type 2 to superinfection by herpes simplex viruses.

Authors:  E Doller; R Duff; F Rapp
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

Review 8.  The oncogenic DNA viruses: a review of in vitro transformation studies.

Authors:  P H Black
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

9.  Chemotherapy and immunotherapy of three human lymphomas serially transplantable in the neonatal Syrian hamster.

Authors:  R A Adams; A Flowers; R Sundeen; L P Merk
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

10.  Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence.

Authors:  J M Seigneurin; C Desgranges; M F Lavoue; G de-The
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

View more
  7 in total

1.  Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines.

Authors:  D Matteucci; M Paglianti; A M Giangregorio; M R Capobianchi; F Dianzani; M Bendinelli
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  The role of epithelial cell differentiation in the expression of herpes simplex virus type 1 in normal human oral mucosa in culture.

Authors:  Y Yura; H Iga; K Terashima; H Yoshida; T Yanagawa; Y Hayashi; M Sato
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32.

Authors:  Y Yura; K Terashima; H Iga; T Yanagawa; H Yoshida; Y Hayashi; M Sato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.

Authors:  L M Lamontagne; J M Dupuy
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

6.  Persistent Varicella-Zoster virus infection in a human rhabdomyosarcoma cell line and recovery of a plaque variant.

Authors:  J P Iltis; J Vette; G A Castellano; D L Madden; J L Sever
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway.

Authors:  Cristina Barreca; Peter O'Hare
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.